Page last updated: 2024-08-25

rosiglitazone and Adolescent Obesity

rosiglitazone has been researched along with Adolescent Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arslanian, S; Chan, CL; Chernausek, SD; El Ghormli, L; Gandica, RG; Gubitosi-Klug, R; Haymond, MH; Levitsky, LL; Siska, M; Willi, SM	1

Trials

1 trial(s) available for rosiglitazone and Adolescent Obesity

Article	Year
Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure. Pediatric diabetes, 2020, Volume: 21, Issue:4 Topics: Adolescent; Child; Combined Modality Therapy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucokinase; Hepatocyte Nuclear Factor 4; Humans; Insulin Resistance; Insulin-Secreting Cells; Life Style; Longitudinal Studies; Male; Metformin; Mutation; Pediatric Obesity; Risk Reduction Behavior; Rosiglitazone	2020

Article

Year

Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.

Pediatric diabetes, 2020, Volume: 21, Issue:4

Topics: Adolescent; Child; Combined Modality Therapy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucokinase; Hepatocyte Nuclear Factor 4; Humans; Insulin Resistance; Insulin-Secreting Cells; Life Style; Longitudinal Studies; Male; Metformin; Mutation; Pediatric Obesity; Risk Reduction Behavior; Rosiglitazone

2020